Randall Friese, MD, and Rein Anton, MD, PhD, will lead the study, examining a new drug designed to protect and regenerate spinal nerves after acute spinal cord injury. Patients must be treated within 12 hours of injury and medication is given for 28 days, according to the report.
Patients are randomized either to receive the drug or a placebo.
More articles on spine surgery:
Orthopedist vs. neurosurgeon for elective spine surgeries: Does it make a difference?
Spine Team Texas wins LIVING magazine’s Reader’s Choice award
21 spine, neurosurgeons on the move
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
